rxstat › Shortages › Eslicarbazepine

Eslicarbazepine (Aptiom) shortage status

Discontinued

Source: Health Canada shortage reports · Updated Oct 27, 2026

Eslicarbazepine products have been discontinued in Canada. See the reports below for which products and when.

An anticonvulsant used to help control partial-onset seizures in epilepsy.

Products affected
0 / 4
Reports on file
10

Reports by product

The DIN is printed on your prescription label.

Discontinued
APTIOM
400MG · TABLET · SUMITOMO PHARMA CANADA, INC.
DIN 02426870
Discontinued
APTIOM
600MG · TABLET · SUMITOMO PHARMA CANADA, INC.
DIN 02426889
Discontinued
APTIOM
800MG · TABLET · SUMITOMO PHARMA CANADA, INC.
DIN 02426897
Discontinued
APTIOM
200MG · TABLET · SUMITOMO PHARMA CANADA, INC.
DIN 02426862
Resolved
APTIOM
400MG · TABLET · SUMITOMO PHARMA CANADA, INC.
DIN 02426870 · ended Jun 30, 2026 · Requirements related to complying with good manufacturing practices.
Resolved
APTIOM
600MG · TABLET · SUMITOMO PHARMA CANADA, INC.
DIN 02426889 · ended Jun 30, 2026 · Requirements related to complying with good manufacturing practices.
Resolved
APTIOM
200MG · TABLET · SUMITOMO PHARMA CANADA, INC.
DIN 02426862 · ended Jun 30, 2026 · Business Reasons
Avoided
APTIOM
800MG · TABLET · SUMITOMO PHARMA CANADA, INC.
DIN 02426897 · ended Oct 28, 2024 · Delay in shipping of the drug.
Avoided
APTIOM
200MG · TABLET · SUMITOMO PHARMA CANADA, INC.
DIN 02426862 · ended May 30, 2024 · Delay in shipping of the drug.
Resolved
APTIOM
400MG · TABLET · SUMITOMO PHARMA CANADA, INC.
DIN 02426870 · ended Apr 15, 2024 · Delay in shipping of the drug.

What's happening

One or more Eslicarbazepine products have been permanently discontinued by their manufacturers. If your product is affected, ask your pharmacist about equivalent products still on the market.

Eslicarbazepine is classified under “ANTIEPILEPTICS” (ATC N03AF).

Recent changes

Common questions

What is Eslicarbazepine used for?

An anticonvulsant used to help control partial-onset seizures in epilepsy.

When will Eslicarbazepine be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Eslicarbazepine in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Related drugs (antiepileptics)

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.